Archive for the ‘General Biotechnology’ Category


This site has moved

February 22, 2006

This site has moved to


The Inaugural Carnival of Biotechnology

February 21, 2006

Welcome to the inaugural Carnival of Biotechnology. This roundup of the best blogs on biotechnology brings together the best posts covering the industry.

This week’s carnival is hosted here at The next post will be at Biotechnology.

For more information about the Carnival of Biotechnology, see the Carnival’s homepage.

Without further ado, here’s this week’s entry:

Finance and business development

Ben McClure at at Investopedia has put together a sample case of Using DCF In Biotech Valuation. This excellent tutorial provides a clear example of how to apply this commonly used biotech valuation tool.


The Drugwonks aren’t bashful in their critique of price controls. In ‘Of Barn Doors and Horses‘ they bemoan the ineffecient circle of impeding vaccine development through price controls, tort liabilities and other factors while providing government incentives to foster the development of vaccines.

In a trifecta of posts directed at reimportation, the Drugwonks explain that Counterfit Drugs are a Global Problem, imported drugs shouldn’t be used Because They’re Illegal and Unsafe and ask Who’s Next, given the dramatic increase in counterfit drugs seizures over the past decade.

See you next time at Biotechnology.


Announcing the Carnival of Biotechnology

February 13, 2006

The Carnival of Biotechnology is a regular roundup of the best blog posts on biotechnology. The carnival is guest-hosted by different sites, ensuring diversity in content and viewpoints. Check out the info page and submit your article or sign up to host the carnival.


Free market for biotech patents?

January 29, 2006

This blog post and the ensuing discussion present an interesting and revealing dialogue on the practicality of creating an open marketplace for biotech patents; the benefits of open-licensing must be weighed against the high capital and time requirements for vetting and development.


Will Human Genome Sciences finally be able to manufacture something in its new plant?

January 2, 2006

HGS recently completed a $225 million factory to make products that still don’t exist…



December 18, 2005

‘Canadian’ pharmacies not actually in Canada…
An investigation conducted by the U.S. Food and Drug Administration found a significant percentage of drugs touted as Canadian and shipped from Internet pharmacy websites claiming to be Canadian were not actually from Canada.



December 8, 2005

Scripps Institute proposes new Florida site for biotech park
The California-based Scripps Research Institute has told Palm Beach County commissioners that it now prefers to build its planned biotechnology park at the Florida Atlantic campus in Jupiter, a decision that came two weeks after construction on the original site near the Everglades was halted.